Kalden
Impact in
- Rheumatology top 5%
- Rheumatoid Arthritis Research and Therapies
- Otitis Media and Relapsing Polychondritis
- Systemic Lupus Erythematosus Research
- Osteoarthritis Treatment and Mechanisms
-
- HIV Research and Treatment
Papers in
- Rheumatology 13
- Rheumatoid Arthritis Research and Therapies 10
- Systemic Lupus Erythematosus Research 3
- Osteoarthritis Treatment and Mechanisms 2
- Immunology 10
- T-cell and B-cell Immunology 4
- Immunodeficiency and Autoimmune Disorders 3
- Immune Response and Inflammation 3
- Co-authors
- W J Irvine (3 shared papers)S Alsalameh (4 shared papers)Harald Burkhardt (1 shared paper)Bernhard Manger (5 shared papers)H Stöß (1 shared paper)Felix Scheuplein (1 shared paper)J. Mollenhauer (1 shared paper)Jürgen Braun (1 shared paper)
- Journals
- Scandinavian Journal of Immunology (2 papers)Annals of the Rheumatic Diseases (1 paper)PubMed (28 papers)
- Partner nations
- Germany
In The Last Decade
Kalden
30 papers receiving 334 citations
Peers
Comparison fields: 5 of 49
- Rheumatology 184
- Virology 22
- Behavioral Neuroscience 9
- Immunology 58
- Neurology 30
Countries citing papers authored by Kalden
This map shows the geographic impact of Kalden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kalden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kalden more than expected).
Fields of papers citing papers by Kalden
This network shows the impact of papers produced by Kalden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kalden. The network helps show where Kalden may publish in the future.
Co-authors
The 25 scholars most cited alongside Kalden, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Preferential cellular and humoral immune reactivities to native and denatured collagen types IX and XI in a patient with fatal relapsing polychondritis. | 1993 | 68 |
| 2 | 1999 | 38 | |
| 3 | Studies on experimental autoimmune thymitis in guinea-pigs. | 1969 | 34 |
| 4 | Antigenicity and accessory cell function of human articular chondrocytes. | 1991 | 32 |
| 5 | The role of antineutrophil cytoplasm antibodies, anticardiolipin antibodies, von Willebrand factor antigen, and fibronectin for the diagnosis of systemic vasculitis. | 1991 | 31 |
| 6 | Positive influence of the Delta32CCR5 allele on response to highly active antiretroviral therapy (HAART) in HIV-1 infected patients. | 2000 | 24 |
| 7 | Regulation of granulocyte macrophage colony stimulating factor production by human articular chondrocytes. Induction by both tumor necrosis factor-alpha and interleukin 1, downregulation by transforming growth factor beta and upregulation by fibroblast growth factor. | 1994 | 23 |
| 8 | 1998 | 21 | |
| 9 | The effect of hypophysectomy on the immune response. | 1970 | 20 |
| 10 | Experimental myasthenia gravis, myositis and myocarditis in guinea-pigs immunized with subcellular fractions of calf thymus or calf skeletal muscle in Freund's complete adjuvant. | 1973 | 14 |
| 11 | [Long-term remission after i.v. immunoglobulin therapy in acquired antihemophilic factor hemophilia with systemic lupus erythematosus]. | 1991 | 10 |
| 12 | Biologics in the treatment of rheumatoid arthritis and ankylosing spondylitis. | 2010 | 10 |
| 13 | Interferon production in the human mixed lymphocyte culture. | 1981 | 7 |
| 14 | The estimation of circulating immune complexes, C3d, and anti-ds-DNA-antibody serum levels in the monitoring of therapeutic plasmapheresis in a patient with systemic lupus erythematosus. A case report. | 1985 | 7 |
| 15 | Are retroviruses involved in the aetiology of rheumatic diseases? | 1991 | 6 |
| 16 | Infliximab therapy leads to clinical and radiographic benefits in early rheumatoid arthritis patients receiving optimum methotrexate dose | 2004 | 5 |
| 17 | Synovial fluid involvement in null cell acute lymphoblastic leukemia diagnosed with monoclonal antibodies. | 1988 | 4 |
| 18 | WHO/IUIS Standardization Programme. | 1993 | 4 |
| 19 | Determination of complement activating circulating immune complexes and an example for antigen specific immune complex assays. | 1986 | 3 |
| 20 | [Functional tests of the immune system]. | 1979 | 2 |
About Kalden
Kalden is a scholar working on Rheumatology, Immunology, Neurology, Behavioral Neuroscience and Virology, having authored 31 papers that have together received 377 indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (10 papers), T-cell and B-cell Immunology (4 papers), Immunodeficiency and Autoimmune Disorders (3 papers), Immune Response and Inflammation (3 papers), Systemic Lupus Erythematosus Research (3 papers), Vasculitis and related conditions (2 papers), Myasthenia Gravis and Thymoma (2 papers) and Osteoarthritis Treatment and Mechanisms (2 papers). The work is most often cited by research in Rheumatology (184 citations), Virology (22 citations), Behavioral Neuroscience (9 citations), Immunology (58 citations) and Neurology (30 citations). Kalden has collaborated with scholars based in Germany. Frequent co-authors include W J Irvine, S Alsalameh, Harald Burkhardt, Bernhard Manger, H Stöß, Felix Scheuplein, J. Mollenhauer, Jürgen Braun, GS Firestein and Roland Kurrle. Their work appears in journals such as Scandinavian Journal of Immunology, Annals of the Rheumatic Diseases and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.